IRIS
TOFFOLETTI, Eleonora
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.533
AS - Asia 1.280
EU - Europa 1.036
SA - Sud America 208
Continente sconosciuto - Info sul continente non disponibili 158
AF - Africa 27
OC - Oceania 4
Totale 6.246
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.441
SG - Singapore 560
CN - Cina 310
UA - Ucraina 196
IT - Italia 181
BR - Brasile 148
DE - Germania 146
HK - Hong Kong 123
FI - Finlandia 100
VN - Vietnam 88
RU - Federazione Russa 79
SE - Svezia 77
FR - Francia 73
IN - India 54
GB - Regno Unito 53
TR - Turchia 41
IE - Irlanda 35
CA - Canada 34
BD - Bangladesh 26
AR - Argentina 22
CO - Colombia 18
BE - Belgio 14
ES - Italia 14
MX - Messico 14
KR - Corea 13
PL - Polonia 13
TT - Trinidad e Tobago 11
HN - Honduras 10
CZ - Repubblica Ceca 9
AT - Austria 8
JP - Giappone 8
NL - Olanda 8
ID - Indonesia 7
IQ - Iraq 7
ZA - Sudafrica 7
EG - Egitto 6
SA - Arabia Saudita 6
KZ - Kazakistan 5
MY - Malesia 5
NI - Nicaragua 5
RO - Romania 5
AU - Australia 4
CH - Svizzera 4
GT - Guatemala 4
LT - Lituania 4
MA - Marocco 4
PK - Pakistan 4
UZ - Uzbekistan 4
VE - Venezuela 4
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
CW - ???statistics.table.value.countryCode.CW??? 3
EC - Ecuador 3
EU - Europa 3
JM - Giamaica 3
PE - Perù 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BY - Bielorussia 2
CL - Cile 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
SV - El Salvador 2
TG - Togo 2
UY - Uruguay 2
AZ - Azerbaigian 1
BH - Bahrain 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GL - Groenlandia 1
GP - Guadalupe 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MU - Mauritius 1
NE - Niger 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
TN - Tunisia 1
ZM - Zambia 1
Totale 6.094
Salva come PNG Salva come JPEG
Città #
Ashburn 302
Woodbridge 298
Ann Arbor 284
Singapore 260
Chandler 251
Fairfield 238
San Jose 192
Beijing 184
Houston 177
Jacksonville 132
Hong Kong 122
Seattle 110
Wilmington 89
Council Bluffs 87
Dearborn 86
Cambridge 67
Boardman 55
Udine 54
Los Angeles 50
New York 48
Dallas 40
Lauterbourg 38
Munich 37
Princeton 36
Dublin 35
Izmir 35
Trieste 26
Helsinki 24
Ho Chi Minh City 24
Buffalo 20
Turku 20
Mumbai 19
Orem 19
Hefei 18
San Diego 18
São Paulo 18
Phoenix 16
Hanoi 15
Bogotá 14
Brussels 14
Des Moines 14
Dong Ket 14
Milan 14
Redondo Beach 13
Santa Clara 13
Warsaw 12
Seoul 11
Chennai 10
Ogden 10
Atlanta 9
Frankfurt am Main 9
Montreal 9
Nuremberg 9
The Dalles 9
Chicago 8
Denver 8
Pittsburgh 8
Redmond 8
Tokyo 8
Boston 7
Brooklyn 7
London 7
San Francisco 7
Toronto 7
Washington 7
Düsseldorf 6
Kunming 6
Norwalk 6
Ottawa 6
Port of Spain 6
Rio de Janeiro 6
Stockholm 6
Vienna 6
Amsterdam 5
Cairo 5
Da Nang 5
Grafing 5
Madrid 5
Managua 5
Manchester 5
Memphis 5
Mexico City 5
Poplar 5
Prague 5
Querétaro 5
Brasília 4
Haiphong 4
Johannesburg 4
Leicester 4
Nanjing 4
Naples 4
Shanghai 4
Tashkent 4
Turin 4
Venice 4
Caxias do Sul 3
Contagem 3
Guangzhou 3
Hải Dương 3
Kuala Lumpur 3
Totale 3.973
Salva come PNG Salva come JPEG
Nome #
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 231
Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia. 222
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 214
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 211
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories 203
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 202
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years 191
B-cell immune reconstitution after allogenic stem cell transplantation and its role in the development of chronic graft-versus-host disease 189
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 186
Clonality and phenotype in spleens from patients with primary immune thrombocytopenia. 180
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. 177
High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission 174
Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia 174
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia 165
Longitudinal follow-up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogeneic bone marrow transplant 160
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. 159
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 157
Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor 156
T-cell chimerism and clinical outcome after reduced-intensity conditioning allogeneic stem cell transplantation 150
KIR POLYMORPHISM IN REDUCED INTENSITY HLA-ID SIBLING STEM CELL TRANSPLANTATION: IMPACT ON CLINICAL OUTCOME 150
KERATOCONJUNCTIVITIS TREATMENT WITH AUTOLOGOUS SERUM EYE IN PATIENTS WITH SEVERE CHRONIC GVHD 146
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 138
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations. 136
No evidence for B-cell clonality by spectratyping analysis in patients with idiopathic thrombocytopenic purpura undergoing rituximab therapy” 134
Fludarabine-based induction therapy does not overcome the negative effect of bcrp (ABCG2) overexpression on remission duration in adult de novo acute myeloid leukemia patients 124
Clinical presentation, outcome and risk factors of late-onset non-infectious pulmonary complication after allogeneic transplantation 119
JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response 118
WT1 – Gene expression driven pre-emptive treatment with decitabine for molecular relapse of acute myeloid leukemia after allogeneic stem cell transplant 114
null 111
MONITORING OF MINIMAL RESIDUAL DISEASE BY QUANTITATIVE WT1 GENE EXPRESSION AFTER REDUCED INTENSITY CONDITIONING ALLOGENEIC SCT IN ACUTE MYELOID LEUKEMIA 109
OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANT FOR REFRACTORY AND RELAPSED ACUTE MYELOID LEUKEMIA 108
CONCOMITANT OVEREXPRESSION OF BCRP AND FLT3-ITD MUTATION ARE ASSOCIATED WITH POOR PROGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS 108
Longitudinal follow up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogenic bone marrow transplant 105
MULTICENTER PROSPECTIVE CLINICAL TRIAL WITH LOW DOSE GEMTUZUMAB-OZOGAMICIN PLUS FLUDARABINE, CYTARABINE, IDARUBICIN (GO-FLAI) AS INDUCTION THERAPY OF CD33-POSITIVE ACUTE MYELOID LEUKEMIA (AML) PATIENTS YOUNGER THAN 65 YEARS 104
QUANTITATIVE ANALYSIS OF MN1 GENE EXPRESSION FOR EVALUATION OF MINIMAL RESIDUAL DISEASE IN CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA PATIENTS 101
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment-free remission: A study from the “GRUPPO TRIVENETO LMC” 97
Monitoring of minimal residual disease by quantitative WT1 gene expression following reduce intensity conditioning allogenic stem cell transplantation in acute myeloid leukaemia 95
Expression and modulation of S100A4 protein by human mast cells 93
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias 93
Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study 79
High JAK2V617F allele burden in low-risk PV: an additional recommendation to start “early” cytoreduction? Results from a multicentric study 69
Novel e4a2 BCR∷ABL1 transcript with insertion of CSE1L exons 9 and 10 in a CML patient: a case report 67
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers 58
NEXT GENERATION SEQUENCING IN TRIPLE NEGATIVE ESSENTIAL THROMBOCYTHEMIA: IMPACT OF ADDITIONAL MUTATIONS IN RISK ASSESSMENT 54
Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia 47
ABCG2 AND HAVCR2 SNPS ARE ASSOCIATED WITH LONG-TERM TFR MAINTENANCE IN CML PATIENTS 41
PROGNOSTIC IMPACT OF EXTENDED MOLECULAR CHARACTERIZATION BY NEXT-GENERATION SEQUENCING IN INTERMEDIATE RISK ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE INDUCTION CHEMIOTERAPY: A RETROSPECTIVE MONOCENTRIC STUDY 27
Totale 6.246
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022299 0 0 0 21 22 9 22 10 10 54 96 55
2022/2023531 52 48 5 80 48 116 3 61 71 11 24 12
2023/2024143 19 16 5 4 20 18 2 8 14 8 7 22
2024/2025797 23 55 17 22 63 25 65 49 93 45 141 199
2025/20261.691 172 169 115 118 280 136 165 40 123 179 116 78
2026/2027432 40 112 125 155 0 0 0 0 0 0 0 0
Totale 6.246